Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.33 |
| ▸ | GAA | P10253 | 2/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.32 |
| ▸ | NPC1 | O15118 | 2/20 | 0.32 |
| ▸ | RAB9A | P51151 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | PKM | P14618 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17339880 | 0.97 | HSD17B10 (0.34) | HSD17B10MAPTMAPK1GAAALOX15 | |
| SCHEMBL12413317 | 0.74 | — | — | |
| SCHEMBL17795860 | 0.72 | MAPK1 (0.36) | HSD17B10MAPK1GAAALOX15NPC1 | |
| SCHEMBL23938072 | 0.70 | HSD17B10 (0.47) | HSD17B10MAPTMAPK1GAAALOX15 | |
| SCHEMBL20731142 | 0.70 | GAA (0.38) | HSD17B10MAPTMAPK1GAASMN1; SMN2 | |
| SCHEMBL15706624 | 0.69 | — | — | |
| SCHEMBL23938071 | 0.67 | HSD17B10 (0.35) | HSD17B10MAPTMAPK1GAAALOX15 | |
| SCHEMBL17339846 | 0.63 | HSD17B10 (0.33) | HSD17B10MAPTMAPK1GAAALOX15 | |
| SCHEMBL23938174 | 0.62 | LMNA (0.39) | HSD17B10MAPTMAPK1GAANPC1 | |
| SCHEMBL20732205 | 0.62 | KDM4E (0.50) | HSD17B10MAPTMAPK1GAANPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9663611-B2 | Conjugated polymers for electronic devices | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2017-05-30 | — | — | US | disclosed |
| US-9663611-B2 | Conjugated polymers for electronic devices | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2017-05-30 | — | — | US | disclosed |
| US-20150028265-A1 | CONJUGATED POLYMERS FOR ELECTRONIC DEVICES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2015-01-29 | — | — | US | disclosed |
| US-20150028265-A1 | CONJUGATED POLYMERS FOR ELECTRONIC DEVICES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2015-01-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150028265-A1 | CONJUGATED POLYMERS FOR ELECTRONIC DEVICES | EED, EPCAM, GABRE | HSD17B10 3944/4885MAPT 423/4885MAPK1 2148/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.